Search

Displaying results 2191 - 2200 of 7063 in total
  1. Drug

    Ioglucol

    go.drugbank.com/drugs/DB21450
    Experimental

    Ioglucol is a small molecule drug. Ioglucol has a monoisotopic molecular weight of 806.86 Da.

  2. Drug

    Sulfasymazine

    go.drugbank.com/drugs/DB21451
    Experimental

    Sulfasymazine is a small molecule drug. Sulfasymazine has a monoisotopic molecular weight of 307.11 Da.

  3. Drug

    Ervogastat

    go.drugbank.com/drugs/DB21489
    Experimental

    Ervogastat is a small molecule drug. Ervogastat has a monoisotopic molecular weight of 407.16 Da.

  4. Drug

    Amelenodor

    go.drugbank.com/drugs/DB21563
    Experimental

    Amelenodor is a small molecule drug. Amelenodor has a monoisotopic molecular weight of 399.16 Da.

  5. Drug

    Vulolisib

    go.drugbank.com/drugs/DB21567
    Experimental

    Vulolisib is a small molecule drug. Vulolisib has a monoisotopic molecular weight of 423.12 Da.

  6. Drug

    Teprosulvose

    go.drugbank.com/drugs/DB21738
    Experimental

    Teprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.

  7. Drug

    Suvadronabinol

    go.drugbank.com/drugs/DB21741
    Experimental

    Suvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.

  8. Drug

    Neratinib

    go.drugbank.com/drugs/DB11828
    ApprovedInvestigational

    Neratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. Approval was granted to Puma Biotechnology Inc. for the tradename Nerlynx. Neratinib i...

    Categories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  9. Drug

    Chromic chloride

    go.drugbank.com/drugs/DB09129
    Approved

    Chromic chloride, for injection, is a sterile, nonpyrogenic solution intended for use as an additive to solutions for Total Parenteral Nutrition (TPN).

    Mixtures: One-A-day Advance Men's, Great Day/am Formula TabCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Gilteritinib

    go.drugbank.com/drugs/DB12141
    ApprovedInvestigational

    Gilteritinib, also known as ASP2215, is a small molecule part of the FLT3 tyrosine kinase inhibitors that presented a greater selectivity and potency when compared with other agents from this group. … [A40044] Gilteritinib was developed by Astellas Pharma and FDA approved on November 28, 2018.